Details of the Drug

General Information of Drug (ID: DMF7HVU)

• Drug Name: Isatuximab

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Approved	[1]
Plasma cell myeloma	2A83.1	Phase 3	[2]

• Affected Organisms: Humans and other mammals
• ATC Code:
  L01FC02: Isatuximab
  L01FC: CD38 (Clusters of Differentiation 38) inhibitors
  L01F: MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
  L01: ANTINEOPLASTIC AGENTS
  L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
• Cross-matching ID:
  UNII: R30772KCU0
  DrugBank ID: DB14811
  TTD ID: D0JB2J

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [2] ClinicalTrials.gov (NCT04270409) Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma. U.S. National Institutes of Health.